Breaking News

inVentiv, Aprecia Enter Commercialization Pact

inVentiv to launch Aprecia brand and technology platform

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

inVentiv Health and Aprecia Pharmaceuticals entered an exclusive commercialization alliance for the launch the Aprecia brand and technology platform and initial pharmaceutical products.   Aprecia offers the ZipDose product platform using three-dimensional printing (3DP) technology to create fast-melt products. The company has completed clinical development and expects to file its first NDA with the FDA in 2H14. inVentiv will serve as Aprecia’s exclusive provider of commercialization services in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters